190 related articles for article (PubMed ID: 25185241)
1. Pancreatic cancer risk after treatment of Hodgkin lymphoma.
Dores GM; Curtis RE; van Leeuwen FE; Stovall M; Hall P; Lynch CF; Smith SA; Weathers RE; Storm HH; Hodgson DC; Kleinerman RA; Joensuu H; Johannesen TB; Andersson M; Holowaty EJ; Kaijser M; Pukkala E; Vaalavirta L; Fossa SD; Langmark F; Travis LB; Fraumeni JF; Aleman BM; Morton LM; Gilbert ES
Ann Oncol; 2014 Oct; 25(10):2073-2079. PubMed ID: 25185241
[TBL] [Abstract][Full Text] [Related]
2. Stomach cancer risk after treatment for hodgkin lymphoma.
Morton LM; Dores GM; Curtis RE; Lynch CF; Stovall M; Hall P; Gilbert ES; Hodgson DC; Storm HH; Johannesen TB; Smith SA; Weathers RE; Andersson M; Fossa SD; Hauptmann M; Holowaty EJ; Joensuu H; Kaijser M; Kleinerman RA; Langmark F; Pukkala E; Vaalavirta L; van den Belt-Dusebout AW; Fraumeni JF; Travis LB; Aleman BM; van Leeuwen FE
J Clin Oncol; 2013 Sep; 31(27):3369-77. PubMed ID: 23980092
[TBL] [Abstract][Full Text] [Related]
3. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
[TBL] [Abstract][Full Text] [Related]
4. Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
van Eggermond AM; Schaapveld M; Janus CP; de Boer JP; Krol AD; Zijlstra JM; van der Maazen RW; Kremer LC; van Leerdam ME; Louwman MW; Visser O; De Bruin ML; Aleman BM; van Leeuwen FE
Br J Cancer; 2017 Jul; 117(3):306-314. PubMed ID: 28632726
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.
Travis LB; Gospodarowicz M; Curtis RE; Clarke EA; Andersson M; Glimelius B; Joensuu T; Lynch CF; van Leeuwen FE; Holowaty E; Storm H; Glimelius I; Pukkala E; Stovall M; Fraumeni JF; Boice JD; Gilbert E
J Natl Cancer Inst; 2002 Feb; 94(3):182-92. PubMed ID: 11830608
[TBL] [Abstract][Full Text] [Related]
6. Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma.
Geurts YM; Shakir R; Ntentas G; Roberti S; Aznar MC; John KM; Ramroth J; Janus CPM; Krol ADG; Roesink JM; van der Maazen RWM; Zijlstra JM; Darby SC; Aleman BMP; van Leeuwen FE; Cutter DJ; Schaapveld M
JAMA Oncol; 2023 Apr; 9(4):481-489. PubMed ID: 36729438
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.
Krul IM; Opstal-van Winden AWJ; Aleman BMP; Janus CPM; van Eggermond AM; De Bruin ML; Hauptmann M; Krol ADG; Schaapveld M; Broeks A; Kooijman KR; Fase S; Lybeert ML; Zijlstra JM; van der Maazen RWM; Kesminiene A; Diallo I; de Vathaire F; Russell NS; van Leeuwen FE
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):843-853. PubMed ID: 28888722
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.
Travis LB; Hill DA; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Wiklund T; Lynch CF; Van't Veer MB; Glimelius I; Storm H; Pukkala E; Stovall M; Curtis R; Boice JD; Gilbert E
JAMA; 2003 Jul; 290(4):465-75. PubMed ID: 12876089
[TBL] [Abstract][Full Text] [Related]
9. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.
van Leeuwen FE; Klokman WJ; Stovall M; Hagenbeek A; van den Belt-Dusebout AW; Noyon R; Boice JD; Burgers JM; Somers R
J Natl Cancer Inst; 1995 Oct; 87(20):1530-7. PubMed ID: 7563187
[TBL] [Abstract][Full Text] [Related]
10. Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects.
Gilbert ES; Curtis RE; Hauptmann M; Kleinerman RA; Lynch CF; Stovall M; Smith SA; Weathers R; Andersson M; Dores GM; Fraumeni JF; Fossa SD; Hall P; Hodgson DC; Holowaty EJ; Joensuu H; Johannesen TB; Langmark F; Kaijser M; Pukkala E; Rajaraman P; Storm HH; Vaalavirta L; van den Belt-Dusebout AW; Aleman BM; Travis LB; Morton LM; van Leeuwen FE
Radiat Res; 2017 Feb; 187(2):186-195. PubMed ID: 28118119
[TBL] [Abstract][Full Text] [Related]
11. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
[TBL] [Abstract][Full Text] [Related]
12. Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
Conway JL; Connors JM; Tyldesley S; Savage KJ; Campbell BA; Zheng YY; Hamm J; Pickles T
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):35-41. PubMed ID: 27979454
[TBL] [Abstract][Full Text] [Related]
13. Increased pancreatic cancer risk following radiotherapy for testicular cancer.
Hauptmann M; Børge Johannesen T; Gilbert ES; Stovall M; van Leeuwen FE; Rajaraman P; Smith SA; Weathers RE; Aleman BM; Andersson M; Curtis RE; Dores GM; Fraumeni JF; Hall P; Holowaty EJ; Joensuu H; Kaijser M; Kleinerman RA; Langmark F; Lynch CF; Pukkala E; Storm HH; Vaalavirta L; van den Belt-Dusebout AW; Morton LM; Fossa SD; Travis LB
Br J Cancer; 2016 Sep; 115(7):901-8. PubMed ID: 27599043
[TBL] [Abstract][Full Text] [Related]
14. Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
Franklin J; Eichenauer DA; Becker I; Monsef I; Engert A
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD008814. PubMed ID: 28901021
[TBL] [Abstract][Full Text] [Related]
15. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
van den Belt-Dusebout AW; Aleman BM; Besseling G; de Bruin ML; Hauptmann M; van 't Veer MB; de Wit R; Ribot JG; Noordijk EM; Kerst JM; Gietema JA; van Leeuwen FE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1420-9. PubMed ID: 19931732
[TBL] [Abstract][Full Text] [Related]
16. Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.
van Nimwegen FA; Ntentas G; Darby SC; Schaapveld M; Hauptmann M; Lugtenburg PJ; Janus CPM; Daniels L; van Leeuwen FE; Cutter DJ; Aleman BMP
Blood; 2017 Apr; 129(16):2257-2265. PubMed ID: 28143884
[TBL] [Abstract][Full Text] [Related]
17. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE
Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593
[TBL] [Abstract][Full Text] [Related]
18. A pilot study evaluating chemotherapy tolerability for breast cancer patients who have received prior treatment and chest radiation for Hodgkin Lymphoma.
Watson AP; Peterson B; Lee C; Baxstrom K; Turcotte L; Vogel R; Blaes A
Cancer Treat Res Commun; 2018; 15():1-6. PubMed ID: 30207281
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.
Almagro-Casado E; Sánchez A; Cantos B; Salas C; Pérez-Callejo D; Provencio M
Clin Transl Oncol; 2016 Jan; 18(1):99-106. PubMed ID: 26530956
[TBL] [Abstract][Full Text] [Related]
20. Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma.
van Nimwegen FA; Schaapveld M; Cutter DJ; Janus CP; Krol AD; Hauptmann M; Kooijman K; Roesink J; van der Maazen R; Darby SC; Aleman BM; van Leeuwen FE
J Clin Oncol; 2016 Jan; 34(3):235-43. PubMed ID: 26573075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
